scorecard

You Searched For "Novartis" and got 20 results


Sort By:


Business Insider Latest Story Image
2 mins read

Novartis India shares jump more than 6% after parent company announces strategic review

Novartis India shares jumped more than 6 per cent on Monday after the parent company, Novartis AG a…

Business Insider Latest Story Image
3 mins read

Novartis debuted its first integrated sustainability and finance report this year — more companies are likely to follow suit

The global pharmaceutical company, Novartis, released its first-ever integrated social impact repor…

Julia Hood   


Business Insider Latest Story Image
1 min read

Digital hub ''Novartis Biome India'' launched in Hyderabad

Claimed to be the first in Asia, the 'Novartis BiomeIndia' is aimed at boosting connection and inte…

PTI   


Business Insider Latest Story Image
2 mins read

SAP Labs offer the best salaries in India and Cisco the best work-life balance, says survey

German software multinational SAP Labs has been ranked as the top ‘new-age employer’ in India — tha…

Business Insider Latest Story Image
2 mins read

Mylan, Dr Reddy's, Aurobindo, and Torrent Pharma can't sell generic Gilenya that is patented by Novartis

A US court has ordered generic drug makers including Mylan, Dr Reddy's Laboratories, Aurobindo Ph…

Business Insider Latest Story Image
1 min read

Novartis India Q3 net profit declines 40 pc to Rs 8 cr

Revenue from operations of the company stood at Rs 117.46 crore for the quarter under consideratio…

PTI   


Business Insider Latest Story Image
1 min read

Novartis CEO said he was 'completely blindsided' by Michael Cohen contract

Novartis changed CEOs in February, with Narasimhan replacing former CEO Joe Jimenez. Narasimhan was…

Lydia Ramsey   


Business Insider Latest Story Image
4 mins read

Novartis just laid out the playbook for making its $2.1 million gene therapy treatment a blockbuster. Here are the next steps.

Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…

Andrew Dunn   


Business Insider Latest Story Image
4 mins read

Dispensed: Oscar's first moves in Medicare Advantage, uBiome's new board members, and Novartis' CEO's commitment to wearing jeans

Something to keep an eye out for going into the end of July - the Livongo IPO is upon us. On Monday…

Lydia Ramsey   


Ashley Stewart   


Business Insider Latest Story Image
6 mins read

Microsoft just forged a key alliance with the Swiss pharma giant Novartis to win a bigger piece of an $11 billion market

The first is using AI for exploration, seeing whether researchers can sift through Novartis' resear…

Lydia Ramsey   


Business Insider Latest Story Image
5 mins read

Lydia Ramsey   


Business Insider Latest Story Image
2 mins read

Cancer-therapy provider Endocyte spikes 50% after Novartis agrees to buy it for $2.1 billion

"We are thrilled that Novartis recognizes the potential for 177Lu-PSMA-617 to change the treatment …

Ethel Jiang   


Business Insider Latest Story Image
4 mins read

Indian pharma sector is going through an interesting phase with Novartis being the latest

The stand-alone total income from operations of the company declined 4.4% to Rs 224.43 crore during…

Business Insider Latest Story Image
2 mins read

Pharmaceutical companies like Novartis and Lilly are starting to pick up cues from Silicon Valley

The healthcare artificial intelligence market is projected to grow exponentially in the coming dec…

Charlotte Hu   


Business Insider Latest Story Image
3 mins read

The CEO of Swiss pharma giant Novartis voluntarily gave up $400,000 of his bonus, thanks to a controversy swirling around the world's most expensive drug

In applying for approval, Novartis submitted manipulated mice testing data to US regulators, the US…

Andrew Dunn   


Business Insider Latest Story Image
3 mins read

A top Novartis executive says the $225 billion drug giant is planning for a 'doomsday scenario' in cancer treatment

Jay Bradner heads up Novartis's drug research and discovery, as president of the Novartis Institute…

Emma Court,Matt Turner   


Business Insider Latest Story Image
3 mins read

A new Senate report says that Novartis had more contact with Michael Cohen than it let on

"We disagree with the report's conclusion that we issued a misleading public statement regarding th…

Lydia Ramsey   


Business Insider Latest Story Image
6 mins read

Pharma giants like Novartis and Sanofi are betting that the future of healthcare looks more like an app or sensor than a prescription

Another reason for the rise of digital treatments is that drugs just aren't cutting it anymore. We'…

Lydia Ramsey   


Business Insider Latest Story Image
1 min read

Aurobindo and Intas submit binding offers to buyout Teva UK

Teva is selling its assets after it acquired Allergan Plc's generics business for $40.5-billion in …